Literature DB >> 32390066

Why it's Time to Abandon the ICER.

Mike Paulden1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32390066     DOI： 10.1007/s40273-020-00915-5

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

1.  Cost Effectiveness of Digital Interventions for Generalised Anxiety Disorder: A Model-Based Analysis.

Authors:  Dina Jankovic; Pedro Saramago Goncalves; Lina Gega; David Marshall; Kath Wright; Meena Hafidh; Rachel Churchill; Laura Bojke
Journal:  Pharmacoecon Open       Date:  2021-12-27

2.  Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice.

Authors:  Joke Bilcke; Philippe Beutels
Journal:  Med Decis Making       Date:  2021-10-15       Impact factor: 2.583

3.  Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies.

Authors:  Akhil Sasidharan; Bhavani Shankara Bagepally; S Sajith Kumar; Kayala Venkata Jagadeesh; Meenakumari Natarajan
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

4.  Point-of-care diagnostic tests for influenza in the emergency department: A cost-effectiveness analysis in a high-risk population from a Canadian perspective.

Authors:  Stephen Mac; Ryan O'Reilly; Neill K J Adhikari; Robert Fowler; Beate Sander
Journal:  PLoS One       Date:  2020-11-16       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.